Chemed Corp

CHENYSECIK 19584HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 231 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Chemed Corp, Reports and events
Filed	Form	What it is	Accession number
2022-11-0210:04 ET	10-Q	Quarterly reportPeriod 2022-09-30	0001562762-22-000410
2022-10-3116:48 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001562762-22-000404
2022-08-0514:04 ET	8-K	5.02 Departure or appointment of officers or directors	0001562762-22-000343
2022-07-2910:04 ET	10-Q	Quarterly reportPeriod 2022-06-30	0001562762-22-000308
2022-07-2716:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001562762-22-000302
2022-06-2908:17 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits	0001562762-22-000286
2022-05-1711:27 ET	8-K	5.07 Shareholder vote results	0001562762-22-000254
2022-04-2910:13 ET	10-Q	Quarterly reportPeriod 2022-03-31	0001562762-22-000197
2022-04-2616:44 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001562762-22-000191
2022-04-0808:00 ET	DEF 14A	Proxy statementPeriod 2022-05-16	0001157523-22-000406
2022-02-2810:40 ET	10-K	Annual reportPeriod 2021-12-31	0001562762-22-000060
2022-02-2416:41 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001562762-22-000054
2021-11-0109:48 ET	10-Q	Quarterly reportPeriod 2021-09-30	0001562762-21-000385
2021-10-2816:43 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001562762-21-000377
2021-07-3008:19 ET	10-Q	Quarterly reportPeriod 2021-06-30	0000019584-21-000013
2021-07-2717:07 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000019584-21-000011
2021-05-1910:57 ET	8-K	5.07 Shareholder vote results	0001562762-21-000230
2021-04-3009:15 ET	10-Q	Quarterly reportPeriod 2021-03-31	0000019584-21-000009
2021-04-2716:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000019584-21-000007
2021-04-0908:30 ET	DEF 14A	Proxy statementPeriod 2021-05-17	0001157523-21-000442
2021-02-2610:45 ET	10-K	Annual reportPeriod 2020-12-31	0000019584-21-000003
2021-02-2316:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001562762-21-000050
2020-11-0408:31 ET	10-Q	Quarterly reportPeriod 2020-09-30	0000019584-20-000042
2020-10-2916:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000019584-20-000039
2020-09-0106:06 ET	8-K	5.02 Departure or appointment of officers or directors	0000019584-20-000036
2020-07-3109:24 ET	10-Q	Quarterly reportPeriod 2020-06-30	0000019584-20-000033
2020-07-3018:08 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000019584-20-000030
2020-05-1916:01 ET	8-K	5.07 Shareholder vote results	0001562762-20-000204
2020-05-0108:01 ET	10-Q	Quarterly reportPeriod 2020-03-31	0000019584-20-000023
2020-04-2816:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000019584-20-000019
2020-04-2211:00 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0000019584-20-000016
2020-04-1515:00 ET	8-K	8.01 Other events	0000019584-20-000013
2020-04-0909:30 ET	DEF 14A	Proxy statementPeriod 2020-05-18	0001157523-20-000492
2020-03-1311:49 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0000019584-20-000009
2020-02-2614:20 ET	10-K	Annual reportPeriod 2019-12-31	0000019584-20-000006
2020-02-1816:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000019584-20-000003
2019-11-0408:32 ET	10-Q	Quarterly reportPeriod 2019-09-30	0000019584-19-000016
2019-10-3020:43 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000019584-19-000013
2019-09-1709:00 ET	8-K	2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits	0000019584-19-000011
2019-08-0508:59 ET	8-K	7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0000019584-19-000007
2019-07-3108:28 ET	10-Q	Quarterly reportPeriod 2019-06-30	0000019584-19-000003
2019-07-2516:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-19-001587
2019-05-2212:47 ET	8-K	5.07 Shareholder vote results	0001157523-19-001278
2019-05-0208:49 ET	10-Q	Quarterly reportPeriod 2019-03-31	0001157523-19-001041
2019-04-2916:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-19-000930
2019-04-0909:00 ET	DEF 14A	Proxy statementPeriod 2019-05-20	0001157523-19-000780
2019-02-2710:38 ET	10-K	Annual reportPeriod 2018-12-31	0001157523-19-000468
2019-02-2509:00 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001157523-19-000431
2019-02-2016:20 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-19-000392
2018-11-0209:23 ET	10-Q	Quarterly reportPeriod 2018-09-30	0001157523-18-002286

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 09:14 ET. Listed shows no prices and gives no investment advice.